REVANCE THERAPEUTICS INC - NOTE 1.750% 2/1

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Debt / NOTE 1.750% 2/1
Total 13F principal
$0
Principal change
-$187,631,543
Total reported market value
$0
Number of holders
0
Value change
-$237,500,723
Number of sells
17

There are no holders of REVANCE THERAPEUTICS INC - NOTE 1.750% 2/1 as of Q1 2025.